🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06926946
Starting soon Not applicable

SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes

NCT06926946 · tracked via the Priya Life Science India tracker
Sponsor
St. John's Research Institute
Phase
Not applicable
Started
2025-07-31
Last updated
2025-07-23

Condition(s) studied

Acute Renal FailureNeonatal Morbidity

Investigational drug(s) / intervention(s)

Intervention Arm- Cerebral Oximetry + Treatment Guideline

Intervention Arm- Cerebral Oximetry + Treatment Guideline: if the cerebral oximeter shows low values, a pre designed treatment guideline will be followed and corrective actions taken.

Study summary

Cerebral oximetry monitoring allows clinicians to optimize blood flow to the brain and oxygenation using the SafeBoosC treatment guideline. The guideline's interventions aims to stabilize blood pressure and oxygen levels.

As low blood pressure is a risk factor for the development of kidney injury, normalizing blood pressure may decrease the incidence of kidney injury in new-borns who are on ventilator.

Eligibility

Sex
ALL
Min age
1 Day
Max age
28 Days
Healthy volunteers
No
Inclusion Criteria: * \> 28 weeks of gestation Invasively ventilated Exclusion Criteria: * major anomalies

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St. jOhn's Medical college & Hospital Bengaluru Karnataka

More St. John's Research Institute trials in India

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06926946 on ClinicalTrials.gov ↗ ← All trials in India